New Risk • May 18
New minor risk - Dividend sustainability The dividend is not well covered by earnings. The company is paying a dividend despite being loss-making. Dividend yield: 2.6% This is considered a minor risk. Companies that pay out too much of their earnings are at risk of having to reduce or cut their dividend in future. If earnings growth slows or earnings fall, then there may not be enough earnings to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. However, this risk is mitigated by the fact the dividend is covered by cash flows. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 43% per year over the past 5 years. Minor Risk Paying a dividend despite being loss-making. Upcoming Dividend • May 14
Upcoming dividend of HK$0.055 per share Eligible shareholders must have bought the stock before 21 May 2026. Payment date: 17 June 2026. The company is not currently making a profit but it is cash flow positive. Trailing yield: 2.5%. Lower than top quartile of Hong Kong dividend payers (6.7%). Lower than average of industry peers (3.3%). Reported Earnings • Mar 21
Full year 2025 earnings released Full year 2025 results: Revenue: CN¥3.48b (up 3.3% from FY 2024). Net loss: CN¥388.8m (flat on FY 2024). Announcement • Mar 21
Huabao International Holdings Limited, Annual General Meeting, May 11, 2026 Huabao International Holdings Limited, Annual General Meeting, May 11, 2026. Announcement • Mar 10
Huabao International Holdings Limited to Report Fiscal Year 2025 Results on Mar 20, 2026 Huabao International Holdings Limited announced that they will report fiscal year 2025 results on Mar 20, 2026 New Risk • Mar 06
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 45% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Announcement • Jan 28
Huabao International Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2025 Huabao International Holdings Limited provided earnings guidance for the year ended 31 December 2025. For the year, the company expects to record a loss before tax in the range of approximately RMB 263 million to RMB 343 million including
impairment on goodwill and other assets and other provisions. Compared with the loss before tax of approximately RMB 402 million for the corresponding period last year, the loss is expected to decrease by approximately 15% to 35%. The loss before tax for the Year was mainly attributable to 1) sharebased compensation expenses incurred at the level of the Company and its subsidiaries amounting to approximately RMB 98 million; and 2) goodwill impairment loss of the cash-generating unit of Jiahao Foodstuff Limited and its subsidiaries ("Jiahao Food"), under the Company's condiment segment, which is expected to be in the range of approximately RMB 470 million to RMB 530 million. Announcement • Jan 07
Huabao International Holdings Limited Announces Chief Executive Officer Changes, Effective January 7, 2026 The board of directors of Huabao International Holdings Limited announced the following changes in the position of chief executive officer (the CEO) of the Company. The company announced that Ms. Chu Lam Yiu will resign from her position as CEO with effect from January 7, 2026. Ms. Chu will continue to serve as executive director, Chairlady of the Board and Chairlady of the Nomination Committee of the Company. Ms. Chu has confirmed that she has no disagreement with the Board or the Company and that there is no other matter relating to her resignation as CEO that needs to be brought to the attention of the shareholders of the Company (the "Shareholders") and The Stock Exchange of Hong Kong Limited. The Board announces that Mr. Xia Liqun has been appointed as the CEO with effect from January 7, 2026. Mr. Xia, aged 59, holds a Bachelor’s degree in economics and is a certified accountant, certified tax specialist and certified appraiser in China. Mr. Xia has over 30 years of corporate management experience. He previously worked in domestic accounting firms in China and was a senior management member of a foreign invested enterprise in China. Mr. Xia is currently the honorary chairman of the Shanghai Food Additives & Batching Association. Mr. Xia is currently the Chairman of Huabao Flavours & Fragrances Co. Ltd., a subsidiary of the Company and its shares are listed on the ChiNext of the Shenzhen Stock Exchange. Mr. Xia also holds relevant positions in certain subsidiaries of the Company. Upcoming Dividend • Sep 07
Upcoming dividend of HK$0.044 per share Eligible shareholders must have bought the stock before 12 September 2025. Payment date: 10 October 2025. The company is not currently making a profit but it is cash flow positive. Trailing yield: 2.1%. Lower than top quartile of Hong Kong dividend payers (6.6%). Lower than average of industry peers (3.0%). Announcement • Sep 01
Huabao International Holdings Limited Announces Executive Changes, Effective 29 August 2025 The Board of directors of Huabao International Holdings Limited announced that Mr. XIA Liqun, Executive Director, Vice Chairman and President of the Company, will cease to be one of the authorised representatives of the Company with effect from 29 August 2025. The Board further announces that Ms. CHOY Man Har, Executive Director, has been appointed as the Authorised Representative with immediate effect. The Authorised Representative is the principal channel of communication between The Stock Exchange of Hong Kong Limited and the Company for listing matters in general. Declared Dividend • Aug 20
First half dividend of HK$0.044 announced Shareholders will receive a dividend of HK$0.044. Ex-date: 12th September 2025 Payment date: 10th October 2025 Dividend yield will be 2.4%, which is lower than the industry average of 8.1%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is covered by cash flows (71% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. Reported Earnings • Aug 20
First half 2025 earnings released: EPS: CN¥0.037 (vs CN¥0.009 in 1H 2024) First half 2025 results: EPS: CN¥0.037 (up from CN¥0.009 in 1H 2024). Revenue: CN¥1.62b (up 2.5% from 1H 2024). Net income: CN¥118.1m (up 298% from 1H 2024). Profit margin: 7.3% (up from 1.9% in 1H 2024). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Announcement • Jul 18
Huabao International Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2025 Huabao International Holdings Limited provided consolidated earnings guidance for the six months ended 30 June 2025. For the period, the Group is expected to record a profit before tax of approximately RMB 151.2 million to RMB 177.2 million for the Period, representing an increase of approximately 91.3% to 124.3% as compared to approximately RMB 79.0 million for the corresponding period in 2024. Such an increase was primarily attributable to the recognition of an impairment loss of approximately RMB 29.3 million on goodwill, an impairment loss of approximately RMB 20.2 million on other assets, and a provision for impairment of approximately RMB 48.0 million related to an investment in an associate during the same period in 2024, whereas no similar impairment provisions were recognised during the Period. Upcoming Dividend • May 29
Upcoming dividend of HK$0.05 per share Eligible shareholders must have bought the stock before 05 June 2025. Payment date: 27 June 2025. The company is not currently making a profit but it is cash flow positive. Trailing yield: 3.0%. Lower than top quartile of Hong Kong dividend payers (7.7%). Lower than average of industry peers (3.7%). New Risk • May 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 49% per year over the past 5 years. Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (11% average weekly change). New Risk • Apr 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 49% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (11% average weekly change). Declared Dividend • Mar 31
Final dividend of HK$0.05 announced Shareholders will receive a dividend of HK$0.05. Ex-date: 5th June 2025 Payment date: 27th June 2025 Dividend yield will be 3.5%, which is lower than the industry average of 8.1%. Sustainability & Growth The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. Reported Earnings • Mar 30
Full year 2024 earnings released: CN¥0.12 loss per share (vs CN¥0.072 profit in FY 2023) Full year 2024 results: CN¥0.12 loss per share (down from CN¥0.072 profit in FY 2023). Revenue: CN¥3.37b (up 2.0% from FY 2023). Net loss: CN¥385.5m (down 265% from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 17% per year, which means it is performing significantly worse than earnings. Announcement • Mar 29
Huabao International Holdings Limited, Annual General Meeting, May 15, 2025 Huabao International Holdings Limited, Annual General Meeting, May 15, 2025. Announcement • Mar 24
Huabao International Holdings Limited(SEHK:336) dropped from FTSE All-World Index (USD) Huabao International Holdings Limited(SEHK:336) dropped from FTSE All-World Index (USD) Announcement • Mar 18
Huabao International Holdings Limited to Report Fiscal Year 2024 Results on Mar 28, 2025 Huabao International Holdings Limited announced that they will report fiscal year 2024 results on Mar 28, 2025 Valuation Update With 7 Day Price Move • Mar 14
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to HK$2.81, the stock trades at a trailing P/E ratio of 77.3x. Average trailing P/E is 10x in the Chemicals industry in Hong Kong. Total loss to shareholders of 30% over the past three years. Valuation Update With 7 Day Price Move • Oct 14
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to HK$2.46, the stock trades at a trailing P/E ratio of 66.3x. Average trailing P/E is 9x in the Chemicals industry in Hong Kong. Total loss to shareholders of 83% over the past three years. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to HK$2.64, the stock trades at a trailing P/E ratio of 70.4x. Average trailing P/E is 8x in the Chemicals industry in Hong Kong. Total loss to shareholders of 80% over the past three years. Reported Earnings • Aug 31
First half 2024 earnings released: EPS: CN¥0.009 (vs CN¥0.048 in 1H 2023) First half 2024 results: EPS: CN¥0.009 (down from CN¥0.048 in 1H 2023). Revenue: CN¥1.58b (up 3.0% from 1H 2023). Net income: CN¥29.7m (down 81% from 1H 2023). Profit margin: 1.9% (down from 10.0% in 1H 2023). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 49% per year, which means it has not declined as severely as earnings. New Risk • Aug 29
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 38% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 52% per year over the past 5 years. Minor Risk Large one-off items impacting financial results. Announcement • Aug 16
Huabao International Holdings Limited to Report First Half, 2024 Results on Aug 28, 2024 Huabao International Holdings Limited announced that they will report first half, 2024 results on Aug 28, 2024 Upcoming Dividend • May 30
Upcoming dividend of HK$0.05 per share Eligible shareholders must have bought the stock before 06 June 2024. Payment date: 28 June 2024. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of Hong Kong dividend payers (7.5%). Lower than average of industry peers (4.6%). Declared Dividend • Mar 31
Final dividend of HK$0.05 announced Shareholders will receive a dividend of HK$0.05. Ex-date: 6th June 2024 Payment date: 28th June 2024 Dividend yield will be 3.7%, which is lower than the industry average of 8.1%. Sustainability & Growth The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to decline by 67% to shift the payout ratio to a potentially unsustainable range, which is more than the 28% EPS decline seen over the last 5 years. Announcement • Mar 27
Huabao International Holdings Limited, Annual General Meeting, May 14, 2024 Huabao International Holdings Limited, Annual General Meeting, May 14, 2024. Reported Earnings • Mar 27
Full year 2023 earnings released: EPS: CN¥0.072 (vs CN¥0.33 loss in FY 2022) Full year 2023 results: EPS: CN¥0.072 (up from CN¥0.33 loss in FY 2022). Revenue: CN¥3.31b (down 14% from FY 2022). Net income: CN¥233.6m (up CN¥1.29b from FY 2022). Profit margin: 7.1% (up from net loss in FY 2022). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 47 percentage points per year, which is a significant difference in performance. Announcement • Mar 15
Huabao International Holdings Limited to Report Fiscal Year 2023 Results on Mar 26, 2024 Huabao International Holdings Limited announced that they will report fiscal year 2023 results on Mar 26, 2024 Announcement • Sep 15
Huabao International Holdings Limited Declares an Interim Dividend for Six Months Ended 30 June 2023, Payable on or About 12 October 2023 Huabao International Holdings Limited has resolved to declare an interim dividend of HK 1.6 cents per share (2022: nil) for the six months ended 30 June 2023, which are expected to be paid on or about 12 October 2023 to Shareholders whose names appear on the register of members of the Company on 20 September 2023. Upcoming Dividend • Sep 06
Upcoming dividend of HK$0.035 per share at 3.6% yield Eligible shareholders must have bought the stock before 13 September 2023. Payment date: 12 October 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 3.6%. Lower than top quartile of Hong Kong dividend payers (7.7%). Lower than average of industry peers (7.6%). Reported Earnings • Sep 01
First half 2023 earnings released: EPS: CN¥0.048 (vs CN¥0.097 loss in 1H 2022) First half 2023 results: EPS: CN¥0.048 (up from CN¥0.097 loss in 1H 2022). Revenue: CN¥1.54b (down 17% from 1H 2022). Net income: CN¥154.0m (up CN¥467.5m from 1H 2022). Profit margin: 10.0% (up from net loss in 1H 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance. Announcement • Aug 19
Huabao International Holdings Limited to Report First Half, 2023 Results on Aug 30, 2023 Huabao International Holdings Limited announced that they will report first half, 2023 results on Aug 30, 2023 New Risk • Jul 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 42% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (9.6% average weekly change). Upcoming Dividend • Jun 01
Upcoming dividend of HK$0.051 per share at 2.4% yield Eligible shareholders must have bought the stock before 08 June 2023. Payment date: 26 June 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 2.4%. Lower than top quartile of Hong Kong dividend payers (7.9%). Lower than average of industry peers (7.6%). Reported Earnings • Apr 01
Full year 2022 earnings released: CN¥0.33 loss per share (vs CN¥0.22 profit in FY 2021) Full year 2022 results: CN¥0.33 loss per share (down from CN¥0.22 profit in FY 2021). Revenue: CN¥3.83b (down 1.4% from FY 2021). Net loss: CN¥1.05b (down 256% from profit in FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Non-Executive Director Haitao Hou was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Sep 06
Upcoming dividend of HK$0.034 per share Eligible shareholders must have bought the stock before 13 September 2022. Payment date: 06 October 2022. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.9%. Lower than top quartile of Hong Kong dividend payers (8.3%). Lower than average of industry peers (6.1%). Reported Earnings • Aug 28
First half 2022 earnings released: CN¥0.097 loss per share (vs CN¥0.15 profit in 1H 2021) First half 2022 results: CN¥0.097 loss per share (down from CN¥0.15 profit in 1H 2021). Revenue: CN¥1.85b (up 4.7% from 1H 2021). Net loss: CN¥313.5m (down 165% from profit in 1H 2021). Valuation Update With 7 Day Price Move • Jul 15
Investor sentiment deteriorated over the past week After last week's 17% share price decline to HK$5.79, the stock trades at a trailing P/E ratio of 23.8x. Average trailing P/E is 6x in the Chemicals industry in Hong Kong. Total returns to shareholders of 92% over the past three years. Buying Opportunity • Jul 11
Now 23% undervalued Over the last 90 days, the stock is up 42%. The fair value is estimated to be HK$8.06, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 18%. Valuation Update With 7 Day Price Move • Jun 30
Investor sentiment improved over the past week After last week's 32% share price gain to HK$6.04, the stock trades at a trailing P/E ratio of 24.7x. Average trailing P/E is 6x in the Chemicals industry in Hong Kong. Total returns to shareholders of 89% over the past three years. Upcoming Dividend • Jun 07
Upcoming dividend of HK$0.02 per share Eligible shareholders must have bought the stock before 14 June 2022. Payment date: 30 June 2022. Payout ratio is a comfortable 32% and this is well supported by cash flows. Trailing yield: 1.8%. Lower than top quartile of Hong Kong dividend payers (7.7%). Lower than average of industry peers (5.3%). Price Target Changed • Apr 27
Price target decreased to HK$6.50 Down from HK$27.30, the current price target is an average from 2 analysts. New target price is 64% above last closing price of HK$3.96. Stock is down 55% over the past year. The company is forecast to post earnings per share of CN¥0.19 for next year compared to CN¥0.22 last year. Board Change • Apr 27
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Non-Executive Director Jonathan Yan was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Reported Earnings • Mar 30
Full year 2021 earnings: EPS and revenues miss analyst expectations Full year 2021 results: EPS: CN¥0.22 (up from CN¥0.14 in FY 2020). Revenue: CN¥3.88b (flat on FY 2020). Net income: CN¥675.1m (up 61% from FY 2020). Profit margin: 17% (up from 11% in FY 2020). Revenue missed analyst estimates by 11%. Earnings per share (EPS) also missed analyst estimates by 36%. Over the next year, revenue is forecast to grow 7.9%, compared to a 9.8% growth forecast for the industry in Hong Kong. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Mar 22
Investor sentiment improved over the past week After last week's 32% share price gain to HK$4.29, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 6x in the Chemicals industry in Hong Kong. Total returns to shareholders of 28% over the past three years. Valuation Update With 7 Day Price Move • Mar 08
Investor sentiment deteriorated over the past week After last week's 19% share price decline to HK$3.56, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 6x in the Chemicals industry in Hong Kong. Total returns to shareholders of 15% over the past three years. Valuation Update With 7 Day Price Move • Jan 24
Investor sentiment deteriorated over the past week After last week's 65% share price decline to HK$4.86, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 66% over the past three years. Valuation Update With 7 Day Price Move • Dec 09
Investor sentiment deteriorated over the past week After last week's 19% share price decline to HK$18.56, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 562% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at HK$32.47 per share. Valuation Update With 7 Day Price Move • Nov 17
Investor sentiment improved over the past week After last week's 32% share price gain to HK$19.66, the stock trades at a trailing P/E ratio of 53.1x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 568% over the past three years. Executive Departure • Oct 01
Independent Non-Executive Director Chi Keung Wu has left the company On the 30th of September, Chi Keung Wu's tenure as Independent Non-Executive Director ended after 8.2 years in the role. We don't have any record of a personal shareholding under Chi Keung's name. Chi Keung is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 5.83 years. Upcoming Dividend • Sep 06
Upcoming dividend of HK$0.064 per share Eligible shareholders must have bought the stock before 13 September 2021. Payment date: 08 October 2021. Trailing yield: 0.8%. Lower than top quartile of Hong Kong dividend payers (6.6%). Lower than average of industry peers (2.9%). Valuation Update With 7 Day Price Move • Aug 27
Investor sentiment improved over the past week After last week's 22% share price gain to HK$19.68, the stock trades at a trailing P/E ratio of 53.9x. Average forward P/E is 6x in the Chemicals industry in Hong Kong. Total returns to shareholders of 414% over the past three years. Reported Earnings • Aug 23
First half 2021 earnings released: EPS CN¥0.15 (vs CN¥0.015 loss in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: CN¥1.76b (up 2.8% from 1H 2020). Net income: CN¥481.1m (up CN¥526.6m from 1H 2020). Profit margin: 27% (up from net loss in 1H 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 54% per year, which means it is well ahead of earnings. Board Change • Aug 01
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Co-Chair & CEO Lam Yiu Chu was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Jun 11
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥12.86, the stock trades at a trailing P/E ratio of 78.6x. Average trailing P/E is 10x in the Chemicals industry in Hong Kong. Total returns to shareholders of 183% over the past three years. Valuation Update With 7 Day Price Move • May 20
Investor sentiment improved over the past week After last week's 45% share price gain to CN¥11.68, the stock trades at a trailing P/E ratio of 71.9x. Average trailing P/E is 10x in the Chemicals industry in Hong Kong. Total returns to shareholders of 184% over the past three years. 
